All Stories

  1. Vitamin D Assessment Over 48 Weeks in Treatment-Naive HIV Individuals Starting Lopinavir/Ritonavir Monotherapy

    Article • Current HIV Research, January 2021, Bentham Science Publishers

    Dr Kevin W Garey

  2. Ridinilazole for the treatment of Clostridioides difficile infection

    Article • Expert Opinion on Investigational Drugs, February 2019, Taylor & Francis

    Dr Kevin W Garey, Travis Carlson

  3. Environmental transmission of Clostridioides difficile ribotype 027 at a long-term care facility; an outbreak investigation guided by whole genome sequencing

    Article • Infection Control and Hospital Epidemiology, September 2018, Cambridge University Press

    Dr Kevin W Garey

  4. Outcomes associated with Clostridium difficile infection in patients with chronic liver disease

    Article • Epidemiology and Infection, May 2018, Cambridge University Press

    Dr Kevin W Garey

  5. Cadazolid for the treatment of Clostridium difficile

    Article • Expert Opinion on Investigational Drugs, March 2017, Taylor & Francis

    Dr Kevin W Garey

  6. Mechanisms for floor surfaces or environmental ground contamination to cause human infection: a systematic review

    Article • Epidemiology and Infection, October 2016, Cambridge University Press

    Dr Kevin W Garey

  7. metronidazole and clostridium and clinical response

    Article • Antimicrobial Agents and Chemotherapy, July 2015, ASM Journals

    Dr Kevin W Garey

  8. Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDS

    Article • HIV/AIDS - Research and Palliative Care, July 2013, Taylor & Francis

    Dr Kevin W Garey